StonvexLoading…
StonvexStonvexStonvexCore line items from UTL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $536.00M | $494.80M | $557.10M | $563.20M |
Operating Income | $101.20M | $90.60M | $87.10M | $80.50M |
Net Income | $50.20M | $47.10M | $45.20M | $41.40M |
EPS (Diluted) | $2.97 | $2.93 | $2.82 | $2.59 |
Total Assets | $2.13B | $1.79B | $1.67B | $1.59B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $15.60M | $6.30M | $6.50M | $9.00M |
Free Cash Flow OCF − CapEx | $-53.80M | $-44.00M | $-34.00M | $-24.40M |
Shares Outstanding | 17.92M | 16.19M | 16.12M | 16.04M |